DNA vaccine against Ebola virus shows potent and long-term efficacy in preclinical studies
A novel synthetic DNA vaccine developed based on technology pioneered by scientists at The Wistar Institute Vaccine & Immunotherapy Center offers complete protection from Zaire Ebolavirus (EBOV) infection in promising preclinical ...
Oct 10, 2018
0
12